Nonhormonal Therapies for Menopausal Vasomotor Symptoms
Vasomotor symptoms are common during menopause and may have substantial negative effects on quality of life. JAMA Senior Editor Linda Brubaker, MD, MS, discusses nonhormonal therapies for menopausal v...
3 Okt 202317min
Medical Care for Adults Who Survive Childhood Cancer
Approximately 500 000 adults in the US have survived childhood cancer. JAMA Deputy Editor Mary McGrae McDermott, MD, speaks with Smita Bhatia, MD, MPH, University of Alabama, about common medical prob...
26 Sep 202316min
USPSTF Recommendation: Screening for Hypertensive Disorders of Pregnancy
Interview with Esa M. Davis, MD, MPH, USPSTF member and coauthor of Screening for Hypertensive Disorders of Pregnancy: US Preventive Services Task Force Final Recommendation Statement. Hosted by JAMA ...
19 Sep 202314min
Ulcerative Colitis: Diagnosis, Treatment, and Management
Ulcerative colitis (UC) is a chronic inflammatory condition of the colon. Individuals with UC have a lower life expectancy and are at increased risk for colectomy and colorectal cancer. However, many ...
12 Sep 202315min
Gestational Diabetes and Long-Term Cardiometabolic Health
There are long-term cardiometabolic health risks for individuals with pregnancies complicated by gestational diabetes. JAMA Senior Editor Linda Brubaker, MD, MS, discusses these risks with Kartik K. V...
5 Sep 202318min
USPSTF Recommendation: Preexposure Prophylaxis to Prevent Acquisition of HIV
Interview with John B. Wong, MD, USPSTF member and coauthor of Preexposure Prophylaxis to Prevent Acquisition of HIV: US Preventive Services Task Force Recommendation Statement. Hosted by JAMA Editor ...
22 Aug 202314min
Cervical Cancer: The Importance of HPV Testing and Vaccination
Each year approximately 100 000 people in the US are treated for cervical precancer, and about 4000 individuals die from cervical cancer. JAMA Senior Editor Melissa Simon, MD, MPH, and Rebecca B. Perk...
8 Aug 202317min
Monoclonal Antibodies Targeting Amyloid for Alzheimer Disease
In this interview, dementia expert Gil D. Rabinovici, MD, discusses monoclonal antibodies that target beta-amyloid–-including a recent phase 3 trial of donanemab published in JAMA-–and reviews conside...
3 Aug 202328min
